Nabla pricing

About

Nabla makes Nabla Copilot, an ambient AI clinical assistant (a “medical scribe”) that listens to the clinician–patient conversation and turns it into a structured clinical note — drafting the documentation, surfacing real-time intelligence, and pushing it into the EHR so clinicians can stop typing during visits. It runs as a web app, iOS and Android apps, and a Chrome extension, and the company reports it is used by 85,000+ clinicians across 150+ health organizations, citing roughly an hour/day saved on documentation, ~1.5x more appointments per month, and a ~27% reduction in burnout among users.

Nabla was founded in Paris in 2018 by Alexandre Lebrun and Martin Raison (both ex-Facebook AI Research / Wit.ai) and Delphine Groll. Its first product was a consumer “super app for women” — practitioner chat, community content, record centralization and telemedicine, monetized via in-app purchases. In March 2023 it pivoted to Copilot, a GPT-3-powered ambient scribe for clinicians, and that has become the entire business. Nabla has raised about $120M total, including a $24M Series B in January 2024 (led by Cathay Innovation, ~$180M valuation) and a $70M round in June 2025 (led by HV Capital) as the ambient-scribe market heated up against rivals like Abridge, Ambience and Microsoft/Nuance DAX.

For the most current information, visit Nabla.

Pricing summary : How Nabla’s pricing model works

Nabla Copilot is sold per clinician (per seat) — you pay per provider, not per token, per minute, or per API call. There are three tiers. A free individual tier (reported at up to ~30 notes/consultations per month, with unlimited notes for residents and interns) is reachable through a self-serve “Try it for free” signup on the homepage. A paid Pro plan — reported at roughly $119/month per provider — lifts the cap to unlimited notes and adds full EHR integration for individual clinicians and small practices. Enterprise is a quoted annual contract for hospitals and telehealth companies, adding SAML SSO, custom/tailored models, custom integrations and dedicated support.

The important caveat: Nabla does not publish a price list. Its /pricing URL returns a 404, and the site routes you to either “Try it for free” or “Talk to our team.” So while the per-clinician structure is clear, the $119/mo Pro figure is third-party-reported (consistently, across several review aggregators) rather than an official Nabla rate, and the free-tier note cap is likewise reported, not posted.

What makes this different: in a category where almost every enterprise healthcare-AI scribe is demo-and-quote only, Nabla keeps a genuinely free, self-serve clinician tier — and even gives residents and interns unlimited notes. That is a deliberate bottom-up, land-and-expand wedge: get individual clinicians (and the next generation of doctors) hooked for free, then convert seats and sell the hospital an Enterprise contract.

Pricing by product

Sales motions across products: self-serve PLG for the Free and (reported) Pro tiers — sign up, scribe your visits, pay per provider — and sales-led for Enterprise (hospital/telehealth deployments with SSO, custom models and a dedicated team). The free residents/interns allowance is the top of a bottom-up funnel into paid seats and enterprise contracts.

Hidden costs : What Nabla users actually pay

Because Nabla is a flat per-seat subscription (not consumption-based), there are no token, minute, or overage meters to blow up your bill — the main “hidden” cost is which tier each clinician actually needs. The free tier’s ~30-note/month cap is the gate: any working clinician seeing a normal patient panel will exhaust it within days and effectively needs the unlimited Pro seat. The residents/interns carve-out is the exception that stays free.

Other things to budget for: the published $119 is unconfirmed — because Nabla quotes paid tiers privately, real per-seat pricing can vary by volume and may be negotiated down at the group/hospital level, so individual sticker price and an enterprise per-seat rate are different conversations. EHR integration is included (not an add-on) on Pro, which removes a common healthcare-IT surcharge. SSO and custom models are Enterprise-only, so security/compliance requirements push you out of the self-serve tiers and into a sales cycle.

Want to estimate your own Nabla bill? Use the Nabla pricing calculator to model your costs based on seat counts.

Pricing evolution : Nabla pricing history and changes

Cadence

Tracked range: 2018–present. Nabla publishes no price page (the /pricing URL 404s) and historical Wayback renders of pricing are essentially absent, so the timeline anchors on the 2023 Copilot launch, the live 2026-06-10 homepage capture, and consistent third-party pricing reports for the paid tiers.

Notable changes

• 2021-04 — Nabla operates as a consumer “super app for women” (practitioner chat, telemedicine, in-app purchases) — a different product and pricing model from today’s scribe.
• 2023-03 — Pivot to Nabla Copilot, a GPT-3 ambient scribe, launched free to clinicians to drive bottom-up adoption — establishing the per-clinician (not per-token) model.
• 2024–2026 — A paid Pro tier (reported ~$119/mo per provider, unlimited notes + EHR) and a quoted Enterprise tier (SAML SSO, custom models) layer on top of the retained free tier; Nabla keeps the price list off its website.

What’s unique : Nabla’s distinctive pricing mechanics

1. A genuinely free, self-serve clinician tier in enterprise health AI. Most ambient scribes (Abridge, Ambience, Nuance DAX) are demo-and-quote only. Nabla keeps a real “Try it for free” signup with a free monthly note allowance — a self-serve wedge into a category that is otherwise entirely sales-led.

2. Unlimited free notes for residents and interns. Rather than just a trial, Nabla gives trainees unlimited notes for free. That seeds the product inside teaching hospitals and habituates the next generation of physicians before anyone signs a contract — a long-horizon, bottom-up land-and-expand mechanic.

3. Per-clinician, not per-token. Despite being an LLM-heavy product, Nabla bills by the clinician seat, not by tokens, minutes, or notes (above the free cap). That makes a paid clinician’s cost completely predictable — a deliberate contrast to consumption-metered AI infra, and a better fit for how hospitals budget headcount.

Strengths & weaknesses

Billing UX : Nabla billing controls and transparency

• Billing controls — Self-serve signup for the free tier (and, where reported, Pro) means a clinician can onboard without a sales call; Enterprise moves to an invoiced annual contract with a dedicated team. Because pricing is per seat, the main “control” is how many provider seats you license.
• Usage visibility — The free tier’s ~30-note/month allowance is the one place usage matters; above that, Pro is flat unlimited, so there is little ongoing usage to monitor. The product surfaces documentation-time-saved metrics to clinicians, which doubles as adoption (not billing) visibility.
• Payment options — Self-serve card billing for individual paid seats (as reported); Enterprise is invoiced under a custom annual contract. Nabla does not publish billing terms publicly, so group/hospital invoicing details are quote-stage.

Strategic wins : Why Nabla’s pricing decisions worked

1. Free clinician entry in a sales-led category

By offering a real free tier and a self-serve signup, Nabla bypassed the slow hospital procurement cycle and let individual clinicians adopt directly — a bottom-up motion that helped it reach 85,000+ clinicians while rivals relied on top-down enterprise sales. See how AI companies structure pricing.

2. Per-seat, not per-token, predictability

Pricing the LLM product per clinician (not per token or minute) makes a paid seat’s cost flat and predictable — which matches how hospitals budget staff and removes the bill-shock risk that plagues consumption-metered AI. Related: choosing the right usage metric.

3. Land on trainees, expand to the hospital

Free unlimited notes for residents and interns plant Nabla inside teaching hospitals and habituate future attendings — turning a pricing concession into a multi-year expansion funnel. See outcome-based pricing trends.

Areas to improve : Gaps in Nabla’s pricing approach

1. No public price list

The paid tiers live entirely off-site (the /pricing URL 404s), so buyers rely on third-party reports for the ~$119/mo figure. Publishing even a Pro list price would shorten self-qualification and reduce the trust gap. See bill shock and cost unpredictability.

2. The free cap is a cliff

A ~30-note/month free allowance is exhausted within days by any working clinician, so the free tier functions as a short trial rather than a durable plan. A clearer “this is a trial, not a tier” framing — or a higher cap — would set expectations better.

3. Compliance gated to Enterprise

SSO and custom models are Enterprise-only, so any clinic with security requirements is pushed into a quote-only sales cycle with no published per-seat economics — slowing mid-market self-qualification.

Key takeaways

1. A free, self-serve tier can break into a sales-led category. Nabla used free clinician access to reach 85,000+ users while ambient-scribe rivals stayed demo-and-quote.
2. Bill per seat, not per token, for predictability. Pricing an LLM product per clinician makes cost flat and budgetable — a deliberate contrast to consumption metering.
3. Free for trainees is a land-and-expand wedge. Unlimited notes for residents/interns seed teaching hospitals and the next generation of buyers.
4. Off-site pricing is a double-edged sword. Keeping no public list preserves enterprise negotiating room but forces buyers onto third-party-reported figures (~$119/mo) and erodes transparency.
5. Healthcare AI is settling on per-clinician seats. Nabla’s structure signals per-provider subscription — not per-token usage — as the emerging default for ambient scribes.

UBP implications

1. Per-seat is a defensible value metric when usage is uniform. A clinician documents a roughly bounded number of visits, so a flat per-provider seat captures value without the forecasting pain of consumption metering. See usage-based pricing strategy.
2. A capped free tier is a usage meter in disguise. Nabla’s ~30-note/month free allowance is a soft consumption gate that qualifies real users into paid seats — a UBP mechanic dressed as a freemium plan.
3. Bottom-up free access compounds in regulated markets. Giving trainees free unlimited usage is a long-horizon acquisition investment that pays off as they become paying attendings — relevant for anyone monetizing inside slow enterprise/regulated buyers.

Sources

• Nabla official website (accessed 2026-06-10) — live homepage capture
• Nabla Copilot pricing & plans — SaaSworthy (accessed 2026-06-10) — Free 30/mo, Pro $119/mo, Enterprise custom
• Nabla AI pricing — eesel AI (accessed 2026-06-10) — Free $0 up to 30 consults; Pro $119/mo unlimited; Enterprise SAML SSO
• Nabla — Reviews, Features, Pricing — revoyant (accessed 2026-06-10) — Freemium, starts at $119/month
• Nabla launches Copilot using GPT-3 — TechCrunch (accessed 2026-06-10)
• Nabla is building a healthcare super app for women — TechCrunch (accessed 2026-06-10)
• Nabla raises $24M Series B — PR Newswire (accessed 2026-06-10)
• Nabla raises $70 million as ambient scribe market heats up — STAT (accessed 2026-06-10)

Bottom line

Nabla Copilot is an ambient AI clinical scribe sold per clinician — and it stands out in a demo-and-quote category by keeping a genuinely free, self-serve tier (reported ~30 notes/month, unlimited for residents and interns). Its paid Pro plan is reported at roughly $119/month per provider for unlimited notes plus EHR integration, and Enterprise is a quoted contract adding SAML SSO and custom models — but Nabla publishes no price list (the /pricing URL 404s), so the paid figures are third-party-reported rather than official. The per-seat (not per-token) structure makes a paid clinician’s cost fully predictable, while free unlimited notes for trainees seed teaching hospitals as a long-horizon land-and-expand funnel. Browse the pricing blueprint for more fully-researched company profiles.

Want to compare Nabla against other healthcare and vertical-AI companies? Browse the pricing blueprint.

Pricing timeline : Major events on a vertical axis

Each milestone below corresponds to a public pricing change, product launch, or material adjustment. Major events use a filled marker; minor adjustments use a faded one.

Free tier + reported ~$119/mo Pro + quoted Enterprise

Jun 2026

Current shape: a free individual tier (reported ~30 notes/mo, unlimited for residents/interns), a paid Pro reported at ~$119/mo per provider (unlimited notes, full EHR integration), and a quoted Enterprise (SAML SSO, custom models, dedicated support). Nabla publishes no price list — the /pricing URL 404s and the homepage routes to 'Try it for free' or 'Talk to our team'.

Launches Nabla Copilot (GPT-3 ambient scribe), free for clinicians

Mar 2023

Nabla pivoted to Copilot, a GPT-3-powered ambient AI assistant that turns the patient conversation into clinical notes. It launched free to clinicians to drive bottom-up adoption, establishing the per-clinician (not per-token) model and the free self-serve entry point.

Women's health 'super app' (pre-scribe)

Apr 2021

Nabla's first product was a consumer healthcare 'super app' for women — practitioner chat, community content, medical-record centralization and telemedicine — monetized via in-app purchases/subscriptions, not a clinician scribe. This is the pre-pivot Nabla; pricing here is irrelevant to the current Copilot product.